The Institute for Global Health Sciences (IGHS) at the University of California, San Francisco hosts the secretariat for the Lancet Commission on TB.
Mike Reid, MD, leads the secretariat and is the driving force behind the commission. He is involved with policy analyses, research and agenda-setting activities related to improving care delivery for people living with HIV, TB and other chronic diseases in sub-Saharan Africa. He is also a clinical provider within the Positive Health Practice "Ward 86" at Zuckerberg San Francisco General Hospital.
Sachin Silva, is a doctoral candidate at the T.H. Chan School of Public Health, Harvard University. His doctoral research focuses on undervaluation in vaccine investment decision-making. The work is both empirically and methodologically motivated and seeks to estimate the economic and social burden of several diseases and develop better methods to evaluate investment in vaccines. He has consulted with the WHO and several national disease control programs to evaluate vaccine candidates for high burden infectious diseases. Sachin’s previous work has also focused on evaluating investment in high-burden disease control programs (such as HIV) and methods to augment financing towards those programs via novel financing mechanisms. Previously, Sachin was a visiting scientist in the department of medicine at Imperial College London and has also had a longstanding career in industry and has advised public and private organizations in product development, strategic management and operations improvement. Prior to Harvard, Sachin received his MSc/DIC in health policy from Imperial College London and received doctoral training at Yale University.
David McKey is executive assistant to the UN Special Envoy. He has substantial global health experience and played a pivotal role in supporting Dr. Goosby during his tenure at Office of the Global AIDS Coordinator (OGAC). He continues to play an indispensable role ensuring the smooth running of the office of the UN Special Envoy.